Literature DB >> 14630212

Molecular mechanisms of active zone function.

Christian Rosenmund1, Jens Rettig, Nils Brose.   

Abstract

In response to incoming action potentials the presynapse exocytoses neurotransmitter filled vesicles. Proper information encoding requires that the release occurs exactly at the junction to the postsynapse, that it is temporally tightly coupled to the electrical signal and that it proceeds efficiently. This review discusses the structure and function of the active zone, which is defined as the region of the presynapse that is specialized for vesicle release. Particular emphasis is put on the molecular players that control spatial restriction, efficiency and timing of exocytosis in the mammalian nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630212     DOI: 10.1016/j.conb.2003.09.011

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  42 in total

1.  Single molecule observation of liposome-bilayer fusion thermally induced by soluble N-ethyl maleimide sensitive-factor attachment protein receptors (SNAREs).

Authors:  Mark E Bowen; Keith Weninger; Axel T Brunger; Steven Chu
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

2.  A new platform to study the molecular mechanisms of exocytosis.

Authors:  Aviv Mezer; Esther Nachliel; Menachem Gutman; Uri Ashery
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

Review 3.  Molecular mechanism of active zone organization at vertebrate neuromuscular junctions.

Authors:  Hiroshi Nishimune
Journal:  Mol Neurobiol       Date:  2011-12-02       Impact factor: 5.590

4.  Location and function of vesicle clusters, active zones and Ca2+ channels in the lamprey presynaptic terminal.

Authors:  Huzefa Photowala; Rachel Freed; Simon Alford
Journal:  J Physiol       Date:  2005-09-01       Impact factor: 5.182

5.  ELKS, a protein structurally related to the active zone-associated protein CAST, is expressed in pancreatic beta cells and functions in insulin exocytosis: interaction of ELKS with exocytotic machinery analyzed by total internal reflection fluorescence microscopy.

Authors:  Mica Ohara-Imaizumi; Toshihisa Ohtsuka; Satsuki Matsushima; Yoshihiro Akimoto; Chiyono Nishiwaki; Yoko Nakamichi; Toshiteru Kikuta; Shintaro Nagai; Hayato Kawakami; Takashi Watanabe; Shinya Nagamatsu
Journal:  Mol Biol Cell       Date:  2005-05-11       Impact factor: 4.138

6.  Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release.

Authors:  Susanne Schoch; Tobias Mittelstaedt; Pascal S Kaeser; Daniel Padgett; Nicole Feldmann; Vivien Chevaleyre; Pablo E Castillo; Robert E Hammer; Weiping Han; Frank Schmitz; Weichun Lin; Thomas C Südhof
Journal:  EMBO J       Date:  2006-11-23       Impact factor: 11.598

7.  Identification of endophilins 1 and 3 as selective binding partners for VGLUT1 and their co-localization in neocortical glutamatergic synapses: implications for vesicular glutamate transporter trafficking and excitatory vesicle formation.

Authors:  Stephanie De Gois; Elisabeth Jeanclos; Marie Morris; Sukhjeevan Grewal; Helene Varoqui; Jeffrey D Erickson
Journal:  Cell Mol Neurobiol       Date:  2006-05-19       Impact factor: 5.046

8.  Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens.

Authors:  Yan-fang Xia; Li He; Jennifer L Whistler; Gregory O Hjelmstad
Journal:  Neuropsychopharmacology       Date:  2007-06-06       Impact factor: 7.853

9.  Crystal structure of the RIM1alpha C2B domain at 1.7 A resolution.

Authors:  Rong Guan; Han Dai; Diana R Tomchick; Irina Dulubova; Mischa Machius; Thomas C Südhof; Josep Rizo
Journal:  Biochemistry       Date:  2007-07-14       Impact factor: 3.162

10.  Unc-51 controls active zone density and protein composition by downregulating ERK signaling.

Authors:  Yogesh P Wairkar; Hirofumi Toda; Hiroaki Mochizuki; Katsuo Furukubo-Tokunaga; Toshifumi Tomoda; Aaron Diantonio
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.